HLA-B and ulcerative colitis: Some specific rare alleles have clinical implications, such as for disease susceptibility (HLA-DRB1*01:03 for Ulcerative colitis: 0.6% frequency)7 or for adverse drug reaction (HLA-B*15:02 for reaction to carbamazepine, 0.3% frequency)28.